Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Clin Toxicol (Phila). 2011 Apr;49(4):298-302. doi: 10.3109/15563650.2011.566882.
OBJECTIVE. To examine the protective effect of bone marrow mesenchymal stem cell (BMSC) transplantation against lung injury induced by paraquat (PQ) poisoning. MATERIALS AND METHODS. Fifty-four female SD rats were randomly divided into four groups: a PQ group, a BMSC treatment group, a BMSC control group, and a normal control group. BMSC, isolated and cultured in vitro, were injected into the tail veins of the rats. The mortality rate, the ratio of lung wet/dry weight, plasma levels of IL-1β, tumor necrosis factor-α (TNF-α), malonaldehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-P(X)), and NF-κBp65 expression in the lung tissues were examined during 14 days after injection. Results. Survival in the PQ group ranged from 8 to 12 days, with an average of 9.6 days. All the rats in the BMSC treatment group survived for more than 14 days. In the BMSC treatment group, the ratio of lung wet /dry weight (P = 0.02 < 0.05), plasma IL-1β and TNF-α levels (P = 0.00 < 0.01), MDA levels (P = 0.03 < 0.05), and expression of NF-κBp65 in the lung tissues (P = 0.00 < 0.01) were significantly lower than those in the PQ group by day 7 post-injection. However, the SOD and GSH-P(X) levels began to increase (P = 0.00 < 0.01) compared with the PQ group. There was no significant difference between the BMSC control group and the normal control group (P > 0.01). DISCUSSION AND CONCLUSION. BMSC transplantation may have the potential to protect against PQ-induced lung injury, by reducing lung edema and lipid peroxidation, inhibiting the release of inflammatory mediators. However, the protective effects require time to develop, and early BMSC transplantation may be more evident during the middle and late stages of therapy.
研究骨髓间充质干细胞(BMSC)移植对百草枯(PQ)中毒引起的肺损伤的保护作用。
将 54 只雌性 SD 大鼠随机分为 4 组:PQ 组、BMSC 治疗组、BMSC 对照组和正常对照组。体外分离培养 BMSC 后,尾静脉注射入大鼠体内。注射后 14 天内,观察各组大鼠的死亡率、肺湿/干重比、血浆白细胞介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)、丙二醛(MDA)、超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-P(X))水平以及肺组织 NF-κBp65 表达情况。
PQ 组大鼠的生存时间为 8 至 12 天,平均为 9.6 天。BMSC 治疗组的所有大鼠均存活超过 14 天。在 BMSC 治疗组,肺湿/干重比(P = 0.02 〈 0.05)、血浆 IL-1β和 TNF-α水平(P = 0.00 〈 0.01)、MDA 水平(P = 0.03 〈 0.05)和肺组织 NF-κBp65 表达(P = 0.00 〈 0.01)均明显低于 PQ 组注射后 7 天。然而,SOD 和 GSH-P(X)水平开始升高(P = 0.00 〈 0.01),与 PQ 组相比。BMSC 对照组与正常对照组之间无显著差异(P 〉 0.01)。
BMSC 移植可能通过减轻肺水肿和脂质过氧化、抑制炎症介质释放来对抗 PQ 引起的肺损伤,具有潜在的保护作用。然而,保护作用需要时间来发挥,早期 BMSC 移植在治疗的中晚期可能更为明显。